Tagged Content

Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Addyi Antipsychotics Belsomra Brintellix Clozapine Cymbalta Daytrana Diazepam Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine/Zyprexa Opioids Rexulti Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vraylar Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2015 FDA approves Vraylar (cariprazine) to treat schizophrenia and bipolar disorder Vraylar capsules approved to treat schizophrenia and bipolar disorder in adults. FDA modifies monitoring for neutropenia in patients using clozapine; approves new REMS program The FDA is changing the requirements for clozapine to address safety concerns about neutropenia, a serious blood condition. The FDA also approves new shared REMS program to improve monitoring and treatment of patients with severe neutropenia.

View all tags
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Free CE for National Recovery Month!
Earn 0.5 contact hours with a free podcast, Transforming Psychiatric Mental Health Care to Recovery Oriented Practice with an Inter-professional Team.  |  Listen Now

New Editor in Chief of APNA's Journal
Geraldine S. Pearson will serve as Editor in Chief of the Journal of the American Psychiatric Nurses Association (JAPNA), effective January 1, 2016.  |  View

APNA Elections Results Are In
See the full list of new members of the Board of Directors and 2016 Election Committee.  |  View

Annual Awards Recipients
Learn more about the 8 psychiatric-mental health nurses honored with 2015 APNA Annual Awards.  |  View